Stay updated on ABT-450/r/ABT-267 and ABT-333 in Asian HCV Clinical Trial
Sign up to get notified when there's something new on the ABT-450/r/ABT-267 and ABT-333 in Asian HCV Clinical Trial page.

Latest updates to the ABT-450/r/ABT-267 and ABT-333 in Asian HCV Clinical Trial page
- ChecktodayChange DetectedThe site revision label changes from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe record now presents details of the completed Phase 3 hepatitis C study, including its eligibility criteria, treatment arms, outcome measures, and study dates, instead of a Forbidden error page.SummaryDifference45%

- Check21 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check28 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.SummaryDifference1%

- Check35 days agoChange DetectedThe ClinicalTrials.gov error page displays an updated site revision number, from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check42 days agoChange DetectedThe footer’s displayed site revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

Stay in the know with updates to ABT-450/r/ABT-267 and ABT-333 in Asian HCV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABT-450/r/ABT-267 and ABT-333 in Asian HCV Clinical Trial page.